Keyphrases
Placebo
77%
Oxytocin
66%
Unipolar Depression
61%
Israel
46%
Major Depressive Disorder
46%
Methylphenidate
44%
Borderline Personality Disorder
42%
Addiction
42%
HF-rTMS
42%
Intranasal Oxytocin
42%
Bipolar Depression
42%
Oxytocin Administration
40%
Healthy Controls
40%
Depressed Patients
40%
Treatment-resistant Depression
39%
Randomized Controlled Trial
35%
Therapist
34%
Attention Deficit Hyperactivity Disorder
34%
Response to Treatment
34%
Israeli
33%
Psychiatric Inpatients
33%
Schizophrenia
31%
Placebo Treatment
30%
Clinical Correlation
28%
Ethical Boundaries
28%
General Psychiatry
28%
Harm Reduction
28%
Electroconvulsive Therapy
28%
Attention Deficit Hyperactive Disorder
28%
Psychiatrists
26%
Therapeutic Alliance
26%
Antidepressant Treatment
26%
Antidepressants
25%
Continuous Performance Test
25%
Depression Treatment
24%
Medical Treatment
23%
Pain Intensity
23%
Response Predictors
21%
Treatment Outcome
21%
Severe Mental Illness
20%
Clinical Setting
20%
Treatment Adherence
19%
Hospitalization
19%
World Wide Web
19%
Pain Perception
19%
Pain Modulation
19%
Drug Use
18%
Add-on Treatment
18%
Depressive Symptoms
18%
Pain Processing
18%
Psychology
Oxytocin
100%
Attention Deficit Hyperactivity Disorder
66%
Adolescents
57%
Methylphenidate
46%
Informed Consent
45%
Self-Report Questionnaire
37%
Attention Deficit
32%
Depression
32%
Problematic Behavior
28%
Substance Abuse
28%
Borderline Personality Disorder
28%
Pain Perception
28%
Placebo Effect
26%
Mental Health
18%
State Anxiety
17%
Mental Illness
17%
Psychiatric Disorder
16%
Facebook
14%
Mental State
14%
Depression
14%
Bipolar Depression
14%
Personality Disorder
14%
Decision Making
14%
Suggestibility
14%
Anorexia
14%
Healthcare
14%
Electroconvulsive Therapy
14%
Adult ADHD
14%
Nicotine Dependence
14%
Magnetoencephalography
14%
Response Inhibition
14%
Inhibition
14%
Schizophrenia
14%
Major Depression
14%
Psychotic Disorder
14%
Motivational Interviewing
14%
Fibromyalgia
14%
Congruence
14%
Electroencephalography
14%
Autonomy
11%
Psychological Well-Being
11%
Healthy Lifestyle
9%
Social Interaction
9%
Pharmacological Treatment
8%
Multi-Level Modeling
7%
Cognitive Bias
7%
Nervous System
7%
Patient with Depression
7%
Comorbidity
7%
Facial Expression
7%